Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

October 5, 2021

Conditions
Dermatomyositis
Interventions
DRUG

Lenabasum 20 mg

oral capsule

DRUG

Lenabasum 5 mg

oral capsule

DRUG

Placebo

oral capsule

Trial Locations (54)

6000

UMHAT, Stara Zagora

10021

Hospital for Special Surgery, New York

12850

Revmatologicky ustav, Prague

15261

University of Pittsburgh, Division of Rheumatology, Pittsburgh

19104

University of Pennsylvania, Philadelphia

20001

Georgetown University, Washington D.C.

21224

Johns Hopkins Bayview Medical Center, Baltimore

29425

MUSC: Department of Neurology, Charleston

32224

Mayo Clinic, Jacksonville

33136

University of Miami, Miami

33612

University of South Florida, Tampa

44195

Cleveland Clinic, Cleveland

48109

University of Michigan, Ann Arbor

53217

Rheumatic Disease Center, Glendale

55455

University of Minnesota, Division of Rheumatic and Autoimmune Diseases, Minneapolis

60611

Northwestern University, Chicago

63110

Washington University in St. Louis, St Louis

66160

University of Kansas Medical Center, Kansas City

70115

DelRicht Research, New Orleans

78756

Austin Neuromuscular Center, Austin

80230

Denver Arthritis Clinic, Denver

85018

HonorHealth Neurology, Phoenix

85259

Mayo Clinic, Scottsdale

90095

UCLA Division of Rheumatology, Los Angeles

90211

Attune Health Center, Beverly Hills

95121

University Hospital Policlinico-Vittorio Emanuele, Catania

Unknown

"University Hospital Kaspela Rheumatology Clinic", Plovdiv

"UMHAT St. Ivan Rilski", Sofia

Charite-Universitatsmedizin, Berlin

University Medical Center Goettingen, Göttingen

University of Debrecen, Debrecen

Gunma University Hospital, Gunma

Hokkaido University Hospital, Hokkaido

Yokohama City University Hospital, Kanagawa

Kyoto University Hospital, Kyoto

Tohoku University Hospital, Miyagi

Osaka University Hospital, Osaka

Keio University Hospital, Tokyo

Nippon Medical School Hospital, Tokyo

Wakayama Medical Hospital, Wakayama

KLIMED, Bialystok

Inha University Hospital, Incheon

Hanyang University Hospital, Seoul

Seoul St. Mary's Hospital, Seoul

Vall d'Hebron General Hospital, Barcelona

Hospital 12 Octubre, Madrid

Karolinska University Hospital, Rheumatology Clinic, Stockholm

King's College Hospital NHS Foundation Trust, London

V5Z 4E8

University of British Columbia, Dept. of Dermatology and Skin Science, Vancouver

D- 91054

University Hospital Erlangen Nuremberg, Erlangen

00168

Fondazione Policlinico Universitario A.Gemelli-IRCCS, Roma

35-055

Kliniczny Szpital Wojewodzki Nr 1. im Fryderyka Chopina Klinika Dermatologii, Rzeszów

18-404

KLIMED, Łomża

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Corbus Pharmaceuticals Inc.

INDUSTRY

NCT03813160 - Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis | Biotech Hunter | Biotech Hunter